News & Updates
Filter by Specialty:
Remdesivir cuts mortality in COVID-19 patients requiring no or low-flow oxygen
In a systematic review and individual patient data meta-analysis, the broad-spectrum antiviral agent remdesivir reduced mortality in adult patients hospitalized for COVID-19 who did not require oxygen support or only required low-flow supplementation when the need for oxygen arose.
Remdesivir cuts mortality in COVID-19 patients requiring no or low-flow oxygen
30 Mar 2023
Cardiorespiratory fitness change linked to survival in patients with or without CVD
Changes in cardiorespiratory fitness (CRF) appear to predict the risk of mortality in patients with and without cardiovascular disease (CVD), suggest the results of a study.
Cardiorespiratory fitness change linked to survival in patients with or without CVD
29 Mar 2023
HK data: SGLT2 inhibitors cut risks of respiratory and renal diseases in T2DM
Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risks of respiratory and renal diseases vs dipeptidyl peptidase-4 (DPP-4) inhibitors in patients with type 2 diabetes mellitus (T2DM), researchers from the University of Hong Kong (HKU) have reported.
HK data: SGLT2 inhibitors cut risks of respiratory and renal diseases in T2DM
29 Mar 2023
How to differentiate COVID-19 pneumonia from influenza and bacterial pneumonia on CT?
Arched bridge and/or vacuole signs on CT may support a diagnosis of COVID-19 pneumonia and assist in differentiation from influenza and bacterial pneumonia, a retrospective study by the Chinese University of Hong Kong has revealed.
How to differentiate COVID-19 pneumonia from influenza and bacterial pneumonia on CT?
28 Mar 2023
COVID-19 vaccine risk-benefit ratio favourable for patients with rheumatic diseases
In the CONVIN-SING* study, there was a favourable risk-benefit ratio for COVID-19 vaccination in individuals with autoimmune inflammatory rheumatic diseases (AIIRD) who have received a COVID-19 mRNA vaccine.
COVID-19 vaccine risk-benefit ratio favourable for patients with rheumatic diseases
28 Mar 2023
Hands-free, pocket-size device helps ease breathing for people with COPD
A small positive-expiratory pressure (PEP) device that can be used on-demand shows promise for improving the lives of people with chronic obstructive pulmonary disease (COPD), according to a study.
Hands-free, pocket-size device helps ease breathing for people with COPD
27 Mar 2023
Long-term dupilumab proven safe, effective in children with asthma
Long-term treatment with dupilumab is well tolerated, and its efficacy in children with uncontrolled, moderate-to-severe asthma as seen in the VOYAGE study is consistent, according to the EXCURSION open-label extension study. In addition, patients who switched from placebo to dupilumab has improved rapid lung function.